ISRN Emergency Medicine

Volume 2013 (2013), Article ID 241036, 8 pages

http://dx.doi.org/10.1155/2013/241036

Research Article

Evaluation of Serum Creatine Kinase and Urinary Myoglobin as Markers in Detecting Development of Acute Renal Failure in Severely Injured Trauma Patients

Arulselvi Subramanian,¹ Deepti Sukheeja,¹ Vivek Trikha,² Arbind Kumar Pandey,¹ Venencia Albert,¹ and Ravindra Mohan Pandey³

¹Department of Laboratory Medicine, Jai Prakash Narayan Apex Trauma Centre (JPNATC), AIIMS, New Delhi 110022, India

²Department of Orthopaedics, Jai Prakash Narayan Apex Trauma Centre (JPNATC), AIIMS, New Delhi 110022, India

³Department of Biostatistics, AIIMS, New Delhi 110022, India

Received 1 July 2013; Accepted 4 August 2013

Academic Editors: A. K. Attri and A. Banerjee

Copyright © 2013 Arulselvi Subramanian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Background. Presence of myoglobinuria, particularly in the early phases of renal failure, and elevation of creatinine kinase are seen to correlate with the development of acute renal failure. Aim. To evaluate the efficiency of serum creatine kinase (CK) and urine myoglobin in assessing development of renal failure. Materials and Method. We prospectively studied trauma patients over a period of 3 months. Samples of 107 patients were routinely analyzed on the 1st, 3rd, and 5th days post trauma, for myoglobinuria and serum CK concentration. Results. 107 patients with median age 28 (4–83) yrs were studied, of which 83.2% were males. 56% had head injury, and 17.1% had high injury severity (ISS > 24). Incidence of renal failure was 9.3%. Myoglobinuria was present in 57 patients on admission, 33 on 3rd day and 22 on the 5th day. The association of myoglobinuria with renal failure was statistically insignificant. The cutoff values of serum CK on the 1st, 3rd, and 5th days were ≥1320 IU/L, ≥1146 IU/L, and ≥1754 IU/L, respectively. Mortality rate was 24 (22.4%), of which 6 had renal failure. Conclusion. Myoglobin is clinically insignificant in the detection of renal failure; serum CK is a sensitive predicting marker for the progression of renal failure following traumatic injury.

1. Introduction

Urine myoglobin and serum creatinine kinase (CK) continue to be used as biomarker of rhabdomyolysis, particularly to assesses risk of developing renal failure. Rhabdomyolysis was first described in the victims of crush injury in Sicilian earthquake in Messina in 1908 and those in World War I. Myoglobin is filtered by the kidney and appears in the urine when the plasma concentration exceeds 1.5 mg/dL. Rhabdomyolysis with renal failure is one of the most serious complications of traumatic patients. We sought to determine the predictive validity of urine myoglobin renal failure in posttraumatic patients. Road traffic accident (RTA)/motor vehicle accident (MVA), crush injury, surgery, and any natural disaster trauma are associated with the release of large amount of myoglobin and serum creatinine kinase (CK) into circulation [1]. At high serum concentrations, myoglobin precipitates in the kidney, both through pigment glomerulopathy and obstructive tubulopathy resulting in renal failure.

Creatine phosphokinase (CK) is an enzyme, released into the blood stream on muscle cell disintegration. It exists in three isomeric forms: CK-MM present in muscles, CK-MB present in heart, and CK-BB present in kidneys and brain. Normal range of serum CK in males is 39–308 IU/L and in females is 26–292 IU/L. CK rises in rhabdomyolysis within 12 hours of the onset of muscle injury, peaks in 1–3 days, and declines 3–5 days after the cessation of muscle injury; serum half-life is approximately 36 hours. Failure of CK levels to decrease suggests ongoing muscle injury, and the peak CK level may be predictive of the development of renal failure. The development of renal failure in the presence of rhabdomyolysis with significantly elevated CK is well described [2–4].

Myoglobinuria appears as reddish brown, dark colored urine, when its concentration is very high, that is, >300,000 μg/L, but in less extreme case, myoglobinuria is not grossly visible [5–7]. Urine dipstick test for blood that has positive findings in the absence of red blood cells suggests myoglobinuria. We therein designed the following prospective investigation for urine rapid test specific for myoglobin and serum CK to determine their role in the diagnosis of renal failure.

2. Materials and Methods

2.1. Study Subjects

The study was conducted over a period of three months, that is, from February to March 2011, in traumatic patients admitted to the Emergency Department of Level I Tertiary Care Trauma Center, on road traffic accident, motor vehicle accident, blunt injury under influence of alcohol, or morning walk people. Routine samples which include male and female patients and all age groups of posttraumatic patients were collected. Patients with drug abuse and on anti-psychotics were excluded from the study. The ethical clearance was obtained from the review committee for the purpose of study.

2.2. Data Collection

Data compilation included age, sex, severity of injury, mode of injury, clinical and laboratory investigations on admission, and followup (3rd and 5th days) records. Patients baseline parameters, age, gender, organ failure, sepsis, type of injury, injury severity score, Glasgow coma scale, systolic arterial blood pressure and outcome during hospitalization, were recorded in excel sheet. All of the subjects consecutive 1st, 3rd, and 5th days routine blood examination, such as complete blood cell count, prothrombin time (PT), activated partial thromboplastin time (aPTTs) and biochemistry test (including Renal function test, Liver function test, and electrolytes) were done. In addition, serum CK was measured and presence or absence of urine myoglobin was seen.

For detection of myoglobinuria, urine samples were centrifuged at 3000 rpm for 10 minutes and urine was passed through a 50 kDa cutoff filter. Myoglobin (molecular weight 17.8 kDa) asses the filter whereas the larger hemoglobin (molecular weight 68 kDa) is retained on filter. The filtrate was then tested for myoglobin with hemoglobin dipstick. Positive results were reported as myoglobin detected. The absence of red cells on microscopy confirmed that the discolored urine is caused by myoglobin.

Microscopic examination was done to check for the presence of RBCs, casts, and other types of cells, if present. Serum CK concentration was determined with an immunoturbidimetric assay on Hitachi Roche 902 Automatic Analyzer (Hitachi Medical, Tokyo, Japan).

Patients with hypotension, arrhythmia and on vasopressors were considered to have cardiovascular dysfunction. Patients with the aspartate transaminase (AST) level >80 IU/L or serum bilirubin level >3 mg% were considered to have hepatic dysfunction. Central nervous system dysfunction was defined as patients with severe head injury, that is, GCS <8. Pulmonary dysfunction was defined as the presence of bilateral lung infiltrate or acute respiratory distress syndrome (ARDS) or central venous pressure <18 mm Hg and on mechanical ventilation. Patients with coagulopathy (PT/or aPTT ≥1.5 × times the control) were considered to have hematology dysfunction. ARF for the purpose of our study was defined as serum creatinine levels >2 mg/dL [8, 9].

2.3. Statistical Analysis

Data analysis was performed using SPSS16.0 statistical software. Serum CK levels on 1st, 3rd, and 5th days for the study group were summarized as median ± SD, and myoglobin results were dichotomized on the basis of test positivity and summarized as frequency (%). Categorical variables were compared via‍ ‍‍ ‍ chi-square () analyses and continuous variables were compared with -test. Patients were categorized into groups on the basis of occurrence of any organ system failure; comparison for the difference in levels of CK and myoglobin results was done using -test and chi-square analysis between the groups. values <0.05 were considered significant. Receiver operating curve analysis (ROC) was done to obtain the sensitivity, specificity, and cutoff values for serum CK to identify patients at a risk for developing renal failure after trauma.

3. Results

There were 107 patients with serum CK and urine myoglobin recorded on the 1st, 3rd, and 5th days of admission. The median age of the study group was 28 (4–83) years. Eighty-nine (83.2%) of them were men and 18 (16.8%) women. Table 1 depicts the baseline characteristics of the study group.

Table 1: Baseline characteristics of the study group.

Parameter
Frequency

Age*

Sex

    Men
89 (83.2)

    Women
18 (16.8)

Organ failure

    Yes
58 (54.2)

    No
49 (45.8)

Cardiac failure

    Yes
9 (8.4)

    No
98 (91.6)

Hepatic failure

    Yes
32 (29.9)

    No
75 (70.1)

Renal failure

    Yes
10 (9.3)

    No
97 (90.6)

    Permanent
3 (30)

    Transient
7 (70)

Pulmonary failure

    Yes
23 (21.5)

    No
84 (78.5)

Sepsis

    Yes
4 (3.74)

    No
103 (96.3)

Type of injury

    Head injury

        Severe
38 (35.5)

        Moderate
12 (11.2)

        Minor
10 (9.3)

    Blunt abdomen trauma
12 (11.2)

    Cervical spine injury
3 (2.8)

    Fracture
6 (5.6)

    Faciomaxillary injury
5 (4.6)

    Soft tissue
3 (2.8)

    Electrocuted, suicide, fall, and gunshot
18 (16.8)

Injury severity score

    24
89 (83.1)

    >24
18 (17.1)

Glasgow coma score

    14-15, mild
43 (40.2)

    8–13, moderate
28 (26.2)

    1–7, severe
36 (33.6)

Systolic arterial blood pressure mm of Hg

    Hypotension, <90
8 (7.5)

    Normal, 90–120
60 (56.1)

    Hypertension, >120
39 (36.4)

Coagulopathy

    Yes
21 (19.6)

    No
86 (80.3)

Immediate hospital outcome

    Dead
24 (22.4)

    Discharged
83 (77.6)

Data expressed as percentage or mean ± SD.

The major site of trauma involved was head (56%) (Figure 1). The incidence of renal failure was about 9.3% (10 out of 107 severely injured patients). Urine myoglobin was present in 57 patients on the 1st day, 33 on the 3rd day, and 22 on the 5th day (Figure 2).

Figure 1: Various sites of trauma of the study group.

Figure 2: Myoglobin positivity in urine on admission, day 3 and day 5 of followup.

The study group was categorized into patients who developed renal failure and those who did not, and on admission laboratory values were compared between the two. There was a significant difference in the levels of aPTT (), serum potassium (), blood urea (), and serum CK () on day 1. On day 3, values of hemoglobin were higher in those who did not have renal failure but significantly lower in those who developed renal failure (). The same is with hematocrit (), prothrombin time (), serum sodium (), blood urea (), CK (), and creatinine (). On day 5, levels of hematocrit were higher in patients without renal failure () and levels of serum CK were lower compared to the other group () (Table 2).

Table 2: Comparison of laboratory variables between patients with and without renal failure using t- test.

Parameters
No renal failure
Renal failure
-value

Hemoglobin

    Day 1

0.4

    Day 3

0.01

    Day 5

0.08

Hematocrit

    Day 1

0.6

    Day 3

0.04

    Day 5

0.05

TLC

    Day 1
12050 (3000–38800)
9650 (6800–15500)
0.1

    Day 3
9800 (1440–30600)
7500 (5200–23900)
0.4

    Day 5
9600 (2500–25900)
8900 (4500–21900)
0.8

Platelet counts

    Day 1
159 (40–900)
157 (80–270)
0.9

    Day 3
140 (34–830)
130 (40–180)
0.8

    Day 5
152.5 (58–960)
110 (40–206)
0.1

PT

    Day 1
16.2 (12.7–37.9)
18.25 (15.4–19.1)
0.7

    Day 3
15.75 (13.3–24.8)
17.3 (15–40.1)
<0.001

    Day 5
15.25 (11.9–33.3)
17.4 (15.6–20.9)
0.6

APTT

    Day 1
28.65 (20–55)
31 (21.6–66.1)
0.006

    Day 3
28.4 (18.2–81.8)
31 (26.9–59.4)
0.2

    Day 5
30.4 (18–136.7)
27.85 (24.9–37.7)
0.6

Na

    Day 1

0.50

    Day 3

<0.001

    Day 5

0.28

K

    Day 1

0.04

    Day 3

0.21

    Day 5

0.7

Ca

    Day 1

0.1

    Day 3

0.7

    Day 5

0.5

Urea

    Day 1
24 (7–76)
58 (13–240)
0.05

    Day 3
26 (8–66)
64 (30–227)
0.01

    Day 5
29 (8–79)
83 (33–170)
0.07

Creatinine

    Day 1
0.7 (0.3–2.3)
0.7 (0.2–10.6)
0.5

    Day 3
0.7 (0.3–2.8)
0.8 (0.2–8.1)
0.03

    Day 5
0.5 (0.3–2.1)
0.6 (0.1–5.30)
0.03

CK

    Day 1
287 (4–4730)
620 (4–16923)
<0.001

    Day 3
636.5 (33–5738)
1360 (15–14345)
0.006

    Day 5
416 (7–2540)
1280.5 (1–8222)
0.03

3.1. Comparison of Myoglobin with Incidence of Renal Failure

On the 1st day, 57 patients were found positive for urine myoglobin, out of which 10% developed renal failure (). On the 3rd day, 33 were positive for urine myoglobin out of which 7% developed renal failure (). On the 5th day, 22 were positive for urine myoglobin, out of which 23% developed renal failure (). However, the association of urine myoglobin with renal failure was not observed to be of any statistical significance (Figure 2).

3.1.1. Correlation of Renal Failure with Mortality

The overall mortality rate of the study was 22.4% (24 out of 107) and mortality rate due to renal failure was 60%; that is, 4 patients of the renal failure group survived throughout their hospital stay (Figure 3).

Figure 3: Correlation of incidence of renal failure with in-hospital mortality of the study group.

3.1.2. Correlations of Serum CK and Creatinine

The cutoff value of serum CK on the 1st day was around ≥1320 IU/L by the ROC analysis with sensitivity of 70%, specificity 69%, and 95% confidence interval (CI) of 67–89%. The cutoff value of creatinine, 1st day was around ≥1 mg/dL with sensitivity of 80%, specificity of 79%, and 95% CI of 81–100% (Figure 4(a)). As shown in Figure 5(a) creatinine (mg/dL) and serum CK IU/L are highly correlated. On linear regression of their natural logs, Ln serum , serum CK was significantly related to creatinine, with and ().

(a)

(b)

(c)

Figure 4: ROC curve analysis for serum creatine on admission, day 3 and day 5 of followup in traumatic patients who developed renal failure.

(a)

(b)

(c)

Figure 5: Correlation of creatine (mg/dL) and serum CK (IU/L) on admission, day 3 and day 5 of followup in traumatic patients who developed renal failure.

The cutoff value of serum CK on the 3rd day was around ≥1146 IU/L with sensitivity of 55.5%, specificity of 55.5%, and 95% CI of 54–87% (Figure 4(b)). The cutoff value of creatinine 1st day was around ≥0.9 mg/dL with sensitivity of 90%, specificity of 72% and 95% CI of 79–100% (Figure 5(b)). As shown in Figure 5, creatinine (mg/dL) and serum CK IU/L are highly correlated. On linear regression of their natural logs, Ln serum , serum CK was significantly related to creatinine, with and ().

The cutoff value of serum CK on the 5th day was around ≥1754 IU/L with sensitivity of 75%, specificity of 71%, and 95% CI of 53–92%. The cutoff value of creatinine 5th day was around ≥0.9 mg/dL with sensitivity of 86%, specificity of 85% and 95% CI of 79–100% (Figure 4(c)). As shown in Figure 5(c), Creatinine (mg/dL) and serum CK IU/L are highly correlated. On linear regression of their natural logs, Ln serum , serum was significantly related to creatinine, with and ().

4. Discussion

There are only a limited number of reports on incidence of patients developing renal failure in all types of injured patients who were admitted in a tertiary care trauma centre under red area. Our study comprised 107 patients of average age 28 (30–83) years who were admitted due to various types of trauma, out of which head injured patients were maximum. Patient groups were divided on the basis of type of organ failure and compared. Incidence of renal failure was 10 out of 107 (9.3%) and mortality in this group was 60%. In our study, posttraumatic renal failure (PTRF) was defined as the occurrence of serum creatinine ≥2 mg/dL after admission for trauma. Similar to our study, Gomes et al. also reported that incidence of renal failure varies from less than 0.1% to 18%, with an associated mortality ranging from 7 to 83%.

Acute Dialysis Quality Initiative Group, a panel of international experts in nephrology and critical care medicine, developed and published a set of consensus criteria for a uniform definition and classification of AKI. These criteria, which make up the acronym “RIFLE,” classify renal dysfunction according to the degree of impairment present: there are three grades of severity—risk (R), injury (I), and failure (F)—and two outcome classes—sustained loss (L) of kidney function and end-stage kidney disease (E) [10].

Although the cause of posttraumatic renal failure is likely multifactorial, renal ischemia appears to be a contributing factor in at least half of patients [11]. Rhabdomyolysis generally occurs after a trauma, but it can also be caused by genetic conditions, metabolic disorders, exercise, toxins, infections, and drugs, and so forth [12, 13]. It has become an important issue to prevent the victims of devastating trauma which leads to renal failure. As reported by Thomas and Ibels, ARF due to rhabdomyolysis accounts for up to 9% of all cases of ARF [14].

We also calculated the cutoff values of serum CK for development of renal failure on the 1st, 3rd, and 5th days by ROC analysis which came out to be ≥1320 IU/L, ≥1146 IU/L, and ≥1754 IU/L, respectively, and serum creatinine was also found to be highly correlated with CK. The sensitivity on the 1st, 3rd, and 5th day was 70%, 55.5%, and 75%, respectively. The specificity of serum CK on the 1st, 3rd, and 5th days was 69%, 55.5%, and 71%, respectively. Hence, trauma patients with serum CK values above these cutoffs are more prone to develop renal failure. Erek et al. [15] studied 639 Marmara earthquake patients with acute renal failure due to crush injuries and reported mean CK value to be 23443 IU/L. In our study, on admission mean CK value was 620 IU/L. Incidence of sepsis in their study was 18.9% as compared to 3.7% in the present study.

Oda et al. studied patients having crush syndrome following an earthquake, finding that the risk of renal failure was higher in the patients with serum CK activities greater than 75 000 U/L [1]. In another study done by Smith and Hardcastle on 334 trauma patients, serum CK of >8500 U/L predicted renal failure [16].

In our study on the 1st day, 57 patients were found positive for urine myoglobin by dipstick test, out of which 10% developed renal failure. This association was not found to be statistically significant. A similar study was done by Loun et al. who concluded that the amount of myoglobin recovered after filtration varied from <1 to 38%, and using this method of ultrafiltration/dipstick may result in the misdiagnosis of patients with high myoglobin concentration who are precarious to renal failure when urine myoglobin the <60,000 μg/L [17].

Hence, this study revealed that a rapid urine test for myoglobin and serum can provide rapid and reliable examination for early diagnosis of renal failure in those with any type of minor, major, or severe trauma/road traffic accident (RTA). However, in some of the studies done on patients with rhabdomyolysis, it was concluded that measuring myoglobin and CK levels was not informative in predicting the risk of developing renal failure [18, 19]. Rapid and reliable diagnostic tools may provide invaluable benefit in subsequent management of posttraumatic patients in preventing renal failure and thereby improving their prognosis. However, further studies are required to assess its efficacy in a prospective setup. Limitation of our study is that most of our patients had their urine checked via a Foley catheter collection which may prevent contamination with blood or other tissue fluid and RIFLE criteria of grading was not done.

5. Conclusion

Patients who suffer from severe traumatic injuries are prone to develop renal failure. Hence, screening via biomarkers such as urine myoglobin and serum CK is required. Incidence of renal failure in our study was 9.3%. Although in our study urine myoglobin correlation with renal failure was not proved as statistically significant, further studies are required to prove its role. The cutoff values of serum CK on the 1st, 3rd, and 5th days were ≥1320 IU/L, ≥1146 IU/L, and ≥1754 IU/L, respectively. Hence, evaluating for serum CK in posttraumatic patients can help in early detection of renal failure and improvement in prognosis.

Disclosure

The paper was presented in Trauma Conference 2012 (international) and won the best poster award.

Conflict of Interests

The authors declare that they have no conflict of interests.

Acknowledgment

The authors would like to sincerely thank the chief of trauma centre, Dr. M. C. Misra, for his constant support.

References

J. Oda, H. Tanaka, T. Yoshioka et al., “Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake,” Journal of Trauma—Injury, Infection and Critical Care, vol. 42, no. 3, pp. 470–476, 1997.

M. M. Ward, “Factors predictive of acute renal failure in rhabdomyolysis,” Archives of Internal Medicine, vol. 148, no. 7, pp. 1553–1557, 1988.

D. Roth, F. J. Alarcon, J. A. Fernandez, R. A. Preston, and J. J. Bourgoignie, “Acute rhabdomyolysis associated with cocaine intoxication,” The New England Journal of Medicine, vol. 319, no. 11, pp. 673–677, 1988.

E. K. Rice, N. M. Isbel, G. J. Becker, R. C. Atkins, and L. P. McMahon, “Heroin overdose and myoglobinuric acute renal failure,” Clinical Nephrology, vol. 54, no. 6, pp. 449–454, 2000.

T. B. Briggs and R. R. Smith, “Exertional rhabdomyolysis associated with decerebrate posturing,” Neurosurgery, vol. 19, no. 2, pp. 297–299, 1986.

J. P. Knochel, “Rhabdomyolysis and myoglobinuria,” Annual Review of Medicine, vol. 33, pp. 435–443, 1982.

R. W. Hamilton, M. B. Hopkins III, and Z. K. Shihabi, “Myoglobinuria, hemoglobinuria, and acute renal failure,” Clinical Chemistry, vol. 35, no. 8, pp. 1713–1720, 1989.

E. A. J. Hoste, G. Clermont, A. Kersten et al., “RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis,” Critical Care, vol. 10, no. 3, article R73, 2006.

A. E. Baue, “MOF, MODS, and SIRS: what is in a name or an acronym?” Shock, vol. 26, no. 5, pp. 438–449, 2006.

E. Gomes, R. Antunes, C. Dias, R. Araújo, and A. Costa-Pereira, “Acute kidney injury in severe trauma assessed by RIFLE criteria: a common feature without implications on mortality?” Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, vol. 18, article 1, 2010.

H. H. Rasmussen and L. S. Ibels, “Acute renal failure. Multivariate analysis of causes and risk factors,” The American Journal of Medicine, vol. 73, no. 2, pp. 211–218, 1982.

T. Iitsuka, A. Koyama, M. Kobayashi et al., “Acute renal failure due to rhabdomyolysis—clinical investigation on our 6 cases,” Japanese Journal of Nephrology, vol. 34, no. 3, pp. 317–324, 1992.

V. E. Schulze Jr., “Rhabdomyolysis as a cause of acute renal failure,” Postgraduate Medicine, vol. 72, no. 6, pp. 145–157, 1982.

M. A. Thomas and L. S. Ibels, “Rhabdomyolysis and acute renal failure,” Australian and New Zealand Journal of Medicine, vol. 15, no. 5, pp. 623–628, 1985.

E. Erek, M. S. Sever, K. Serdengeçti et al., “An overview of morbidity and mortality in patients with acute renal failure due to crush syndrome: the Marmara earthquake experience,” Nephrology Dialysis Transplantation, vol. 17, no. 1, pp. 33–40, 2002.

W. A. Smith and T. C. Hardcastle, “A crushing experience: the spectrum and outcome of soft tissue injury and myonephropathic syndrome at an Urban South African University Hospital,” African Journal of Emergency Medicine, vol. 1, no. 1, pp. 17–24, 2011.

B. Loun, K. R. Copeland, and F. A. Sedor, “Ultrafiltration discrepancies in recovery of myoglobin from urine,” Clinical Chemistry, vol. 42, no. 6, pp. 965–969, 1996.

A. H. B. Wu, I. Laios, S. Green et al., “Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure,” Clinical Chemistry, vol. 40, no. 5, pp. 796–802, 1994.

D. A. Feinfeld, J. T. Cheng, T. D. Beysolow, and A. M. Briscoe, “A prospective study of urine and serum myoglobin levels in patients with acute rhabdomyolysis,” Clinical Nephrology, vol. 38, no. 4, pp. 193–195, 1992.